Page last updated: 2024-08-18

4-butyrolactone and Lymphoma, Large B-Cell, Diffuse

4-butyrolactone has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmed, M; Ahmed, SO; Ajarim, D; Al-Dayel, F; Al-Kuraya, KS; Bavi, P; Bu, R; Hussain, AR; Uddin, S	1

Other Studies

1 other study(ies) available for 4-butyrolactone and Lymphoma, Large B-Cell, Diffuse

Article	Year
Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma. Molecular cancer therapeutics, 2010, Volume: 9, Issue:5 Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fatty Acid Synthases; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins c-met; RNA, Small Interfering; Validation Studies as Topic	2010

Article

Year

Inhibition of fatty acid synthase suppresses c-Met receptor kinase and induces apoptosis in diffuse large B-cell lymphoma.

Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

Topics: 4-Butyrolactone; Adult; Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fatty Acid Synthases; Female; Gene Expression Regulation, Neoplastic; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Proto-Oncogene Proteins c-met; RNA, Small Interfering; Validation Studies as Topic

2010